Autopsies Show Varied Forms of Heart Damage in COVID-19 Patients
Autopsies Show Varied Forms of Heart Damage in COVID-19 Patients
The multifarious nature of the damage means treatments for cardiac issues during infection will require tailored approaches.
Autopsies Show Varied Forms of Heart Damage in COVID-19 Patients
Autopsies Show Varied Forms of Heart Damage in COVID-19 Patients

The multifarious nature of the damage means treatments for cardiac issues during infection will require tailored approaches.

The multifarious nature of the damage means treatments for cardiac issues during infection will require tailored approaches.

prosthetics, microbiology, ecology, disease & medicine
p53 as an Immune System Modulator in Cancer
p53 as an Immune System Modulator in Cancer
The Scientist Creative Services Team | Sep 25, 2020
Best known as a cell cycle regulator, p53 signaling mediates pro and anti-cancer immune responses as well
Pandemic Shutdown Altered Bay Area Birdsongs
Pandemic Shutdown Altered Bay Area Birdsongs
Ruth Williams | Sep 24, 2020
As shelter-in-place orders quieted the city of San Francisco, its sparrow population developed softer, sexier songs.
Mass Elephant Die-Off Caused by Cyanobacteria, Officials Say
Mass Elephant Die-Off Caused by Cyanobacteria, Officials Say
Max Kozlov | Sep 23, 2020
Tests point to a toxic algal bloom that might have led to the unprecedented deaths of hundreds of African elephants in Botswana earlier this year, but the evidence isn’t conclusive.
Virus Hunters: Searching for Therapeutic Phages in a Drug Resistant World
Virus Hunters: Searching for Therapeutic Phages in a Drug Resistant World
The Scientist Creative Services Team | Sep 21, 2020
Researchers Jason Gill and Paul Turner will discuss their work on bacteriophage therapy to treat drug resistant bacterial infections.
Algorithm Spots COVID-19 Cases from Eye Images: Preprint
Algorithm Spots COVID-19 Cases from Eye Images: Preprint
Anthony King | Sep 21, 2020
A small study shows artificial intelligence can pick out individuals with coronavirus infections, but ophthalmologists and AI experts say the approach is far from proven to be capable of distinguishing infections with SARS-CoV-2 from other ills.
Antibody-Based Drug May Reduce COVID-19 Hospitalizations: Study
Antibody-Based Drug May Reduce COVID-19 Hospitalizations: Study
Lisa Winter | Sep 17, 2020
Eli Lilly reports a 72 percent reduction in hospitalization risk among patients who received its monoclonal antibody compared to those who received a placebo.
University of Michigan Grad Students Strike over COVID-19 Policy
University of Michigan Grad Students Strike over COVID-19 Policy
Amanda Heidt | Sep 16, 2020
Student workers have cited a lack of transparency and a failure to implement rapid and widespread testing among their many concerns regarding the school’s response to the pandemic.
Indian Study Shows No Survival Benefit of Plasma in COVID-19
Indian Study Shows No Survival Benefit of Plasma in COVID-19
Alakananda Dasgupta | Sep 15, 2020
A randomized controlled trial on the use of convalescent plasma therapy to treat coronavirus infections—the first in the world to be completed—yields disappointing results, but some doctors are not discouraged.
Immune Cell and Its Cytokine Control Exploratory Behavior in Mice
Immune Cell and Its Cytokine Control Exploratory Behavior in Mice
Ashley Yeager | Sep 14, 2020
Gamma delta T cells in the meninges of the brain release a cell signaling molecule that does more than protect mice from microbial pathogens.